Shares Bio Blast Pharma Ltd. Ordinary Shares UNDERWRITING AGREEMENTUnderwriting Agreement • July 15th, 2014 • Bio Blast Pharma Ltd. • Pharmaceutical preparations • New York
Bio Blast Pharma Ltd., a corporation incorporated under the laws of the State of Israel (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of Bio Blast Pharma Ltd., the “Company”), proposes, subject to the terms and conditions contained herein, to sell to you and the other underwriters named on Schedule 1 to this Agreement (the “Underwriters”), for whom you are acting as Representatives (the “Representatives”), an aggregate of ________ shares (the “Firm Shares”) of the Company’s ordinary shares, par value NIS 0.01 per share (the “Ordinary Shares”). The respective amounts of the Firm Shares to be purchased by each of the several Underwriters are set forth opposite their names on Schedule 1 hereto. In addition, the Company proposes to grant to the Underwriters an option to purchase up to an additional ___________ Ordinary Shares (t
AMENDED AND RESTATED SERVICES AGREEMENTServices Agreement • July 15th, 2014 • Bio Blast Pharma Ltd. • Pharmaceutical preparations • Tel-Aviv
THIS AMENDED AND RESTATED SERVICES AGREEMENT (this “Agreement”) is entered into on April 22, 2014 by and between Bio Blast Pharma Ltd. ("Company") and Dalia Megiddo through DM Medica Ltd. (“Service Provider").
